Investor Relations

You are here:

Company Management

ChemoTech is a Swedish public limited liability company. The Company was established in Sweden. The present Company’s date of registration with the Swedish Companies Registration Office is 25 February 2015, and the Company has been in operation since then. The Company complies with the regulations of the Swedish Companies Act (2005:551) and other applicable statutory regulations. The Company is domiciled in Lund, Sweden.

The basis for the Company’s activities is its Articles of Association. In accordance with Article 3 of the Articles of Association, the Company conducts development, production and marketing of medicotechnical equipment, and related activities. The Company’s Annual General Meeting adopts the Articles of Association and annually appoints the Board of Directors. The Board of Directors is responsible for the organisation and management of the Company, and the appointment or dismissal of the CEO. The Board of Directors annually lays down written procedures for its work, combined with CEO instructions for the division of work between the Board of Directors and the CEO. Matters concerning remuneration or auditing are decided directly by the Company’s Board of Directors. All members of the Board of Directors are elected for a term up to the next Annual General Meeting. Each member of the Board of Directors is entitled to resign at any time.

Investor Relations Contact

Mohan Frick, CEO

Scandinavian ChemoTech AB
Medicon Village Scheelevägen 2
SE-223 63 Lund, Sweden

Certified Advisor

The Company’s Certified Adviser is Erik Penser Bank. The Certified Adviser continuously assists and reviews the Company to ensure that it complies with the Nasdaq First North rules and regulations.

Erik Penser Bank
Apelbergsgatan 27
SE-103 91 Stockholm
(+46) (0)8-463 80 00


MAZARS SET Revisionsbyrå AB
Auditor responsible Karin Löwhagen
Deputy auditor Filip Åkesson
Anders Johnsson – Business Unit Director

Business Unit Director Animal Care

Born 1963. Education and experience: M.Sc. Computer Engineering, Lund Institute of Technology. 30 years in leading management-, sales- and marketing positions within the Yggdrasil Group and the Malmöhus Invest Group and others. 10 years of experience in the development and commercialization of electrochemo- and electrogene therapy devices. Current assignments: Member of the board at Bamboo Group…

Danny Nesrallah

National Director of Sales & Business Development Consultant for North America

Contact details: Phone nr: + 1561 299 6267 E-mail:

Elin Wallin

Product specialist

Contact details: Phone nr: + 46 (0) 10 218 93 00 E-mail:

Eva Ståhl Wernersson – QM/RA Director

QM/RA Director

Born 1959. Education and experience: Master of Science in Chemical Engineering, 1985, Doctoral of philosophy in Engineering, 1997 at Lund University. Close to 40 years´ experience from medical technology, biotech and health care companies in roles such as Director Environmental Laboratories, Quality Director and QA/RA specialist consultant. She has held positions in Pharmviva AB, Camurus…

Mohan Frick – CEO

CEO and Founder

Born 1974. Education and experience: BA, Marketing, Management, Lund University. 20 years’ experience as market manager, sales manager and Board member of life science companies. Has among other things held positions in Arjo AB, Getinge, Navigator Communications, Insulution AB, OnMeD and SYSMEX. Current assignments: Chairman of Scandinavian ChemoTech AB (publ), Scandinavian MediTech (Indian subsidiary), Fricks Property…